Post Author: Dr. Khutaija Noor

Khutaija Noor is an acclaimed clinical research physician who has held key roles at distinguished institutions, including Washington University and Amicis Clinical Trials. At Amicis, she leads pivotal FDA-regulated clinical trials, positioning her at the forefront of pharmaceutical innovation. Her original scientific contributions are reflected in publications such as Psychiatric Times, where her work on schizophrenia treatment was featured. She also advises peers nationally through contributions to the Physician Leadership Journal, emphasizing best practices in clinical research.
Dr. Noor completed advanced training at Harvard Medical School and maintains affiliations with both Harvard and Amicis Clinical Trials. Her expertise bridges physical and mental health, with a focus on cultural dimensions of care.

Khutaija Noor is an acclaimed clinical research physician who has held key roles at distinguished institutions, including Washington University and Amicis Clinical Trials. At Amicis, she leads pivotal FDA-regulated clinical trials, positioning her at the forefront of pharmaceutical innovation. Her original scientific contributions are reflected in publications such as Psychiatric Times, where her work on schizophrenia treatment was featured. She also advises peers nationally through contributions to the Physician Leadership Journal, emphasizing best practices in clinical research.
Dr. Noor completed advanced training at Harvard Medical School and maintains affiliations with both Harvard and Amicis Clinical Trials. Her expertise bridges physical and mental health, with a focus on cultural dimensions of care.
For thousands of International Medical Graduates (IMGs) every year, the third week of March is defined by a single, gut-wrenching question: Did I match? The entire future seems to hinge on a single email. We spend years navigating exams, clinical rotations, and visa applications, all for a shot at a residency spot in the United States. But what happens when that email doesn’t bring good news? For many, it feels …
Read more…